IBSA Institut Biochimique SA
IBSA Group is a multinational pharmaceutical company headquartered in Lugano, Switzerland
The production facilities and R&D labs are distributed in Switzerland, Italy, France and China.
IBSA operates in more than 90 countries and 5 continents with 17 subsidiaries in Europe, China and the USA, and employs over 2,000 collaborators distributed among our headquarters, subsidiaries and manufacturing plants.
IBSA holds 90 patent families and many others in development, with a diversified portfolio covering 10 different therapeutic areas.
It is one of the major players worldwide in the field of Reproductive Medicine and one of the world's leaders in hyaluronic acid-based products.
IBSA has 4 pillars:
News

02.02.2023
IBSA at the IMCAS World Congress 2023: innovation and new perspectives for the future of Aesthetic Medicine

26.01.2023
Scientific education and training: for over 10 years at the centre of the activities of IBSA Foundation for scientific research

19.01.2023
The IBSA Pharma UK website is online: the consolidation of the Group in the British market goes on

13.01.2023
IBSA Derma worldwide

23.12.2022
4th Sustainability Report: IBSA continues on its path towards an increasingly more responsible future

22.12.2022
Music, training, inclusion: the year 2022 of Casa dos Curumins

15.12.2022
Healing through music: the second edition of the Cultura e Salute university course at USI

06.12.2022
World Days of 2022: special dates, to raise awareness of social issues and topics of common interest

01.12.2022